According to Pieris Pharmaceuticals's latest financial reports the company's current revenue (TTM) is €35.76 M. In 2022 the company made a revenue of €24.14 M a decrease over the revenue in the year 2021 that were of €27.61 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.